Published online 14 July 2005
Article |
Exonization of AluYa5 in the human ACE gene requires mutations in both 3' and 5' splice sites and is facilitated by a conserved splicing enhancer
echovsk
*University of Southampton School of Medicine, Division of Human Genetics Duthie Building, Mailpoint 808, Southampton SO16 6YD, UK
*To whom correspondence should be addressed. Tel: +44 2380 796425, Fax: +44 2380 794264; Email: igvo{at}soton.ac.uk
Received March 31, 2005. Revised June 13, 2005. Accepted June 27, 2005.
Ancient Alu elements have been shown to be included in mature transcripts by point mutations that improve their 5' or 3' splice sites. We have examined requirements for exonization of a younger, disease-associated AluYa5 in intron 16 of the human ACE gene. A single G>C transversion in position –3 of the new Alu exon was insufficient for Alu exonization and a significant inclusion in mRNA was only observed when improving several potential splice donor sites in the presence of 3' CAG. Since complete Alu exonization was not achieved by optimizing traditional splicing signals, including the branch site, we tested whether auxiliary elements in AluYa5 were required for constitutive inclusion. Exonization was promoted by a SELEX-predicted heptamer in Alu consensus sequence 222–228 and point mutations in highly conserved nucleotides of this heptamer decreased Alu inclusion. In addition, we show that Alu exonization was facilitated by a subset of serine/arginine-rich (SR) proteins through activation of the optimized 3' splice site. Finally, the haplotype- and allele-specific ACE minigenes generated similar splicing patterns in both ACE-expressing and non-expressing cells, suggesting that previously reported allelic association with plasma ACE activity and cardiovascular disease is not attributable to differential splicing of introns 16 and 17.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Pastor, G. Talotti, M. A. Lewandowska, and F. Pagani An Alu-derived intronic splicing enhancer facilitates intronic processing and modulates aberrant splicing in ATM Nucleic Acids Res., September 22, 2009; (2009) gkp778v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Ram, S. Schwartz, and G. Ast Multifactorial Interplay Controls the Splicing Profile of Alu-Derived Exons Mol. Cell. Biol., May 15, 2008; 28(10): 3513 - 3525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Gal-Mark, S. Schwartz, and G. Ast Alternative splicing of Alu exons--two arms are better than one Nucleic Acids Res., April 1, 2008; 36(6): 2012 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sorek The birth of new exons: Mechanisms and evolutionary consequences RNA, October 1, 2007; 13(10): 1603 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, A. Dhir, M. A. Lewandowska, and F. E. Baralle RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events Nucleic Acids Res., July 26, 2007; 35(13): 4369 - 4383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hasler and K. Strub Alu elements as regulators of gene expression Nucleic Acids Res., November 14, 2006; 34(19): 5491 - 5497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF]
|
|